Denmark And Seattle
COPENHAGEN, Denmark and SEATTLE, November 9, 2011 -
Single-use technologies are widely accepted in the biomanufacturing of biological therapeutics and vaccines.
COPENHAGEN, Denmark and SEATTLE, September 1, 2011 -
- Several planned events highlight CMC Biologics' expertise in single-use technology
CMC Biologics today announced the completion of the installation of a 2,000 liter single-use bioreactor (2,000L SUB) at its manufacturing facility in Copenhagen.
COPENHAGEN, Denmark and SEATTLE, Washington, June 22, 2011 -
CMC Biologics today announced that it is in the final stages of
expanding its stainless steel biopharmaceutical production facility
at its Bothell campus and it has rebranded its corporate identity
with an exciting new logo and a compelling tagline.
COPENHAGEN, Denmark and SEATTLE, May 2, 2011 - CMC Biologics, a leading biopharmaceutical Contract Manufacturing
Organization, with operations in Copenhagen, Denmark and Seattle, Washington
USA, announced today that it has hired Claes Glassell to serve at its Chief
Executive Officer.
COPENHAGEN, Denmark and SEATTLE, August 25, 2010 - CMC Biologics, a Contract Manufacturing Organization with manufacturing
sites in Europe and the USA, today announced the completion of a new
state-of-the-art disposable manufacturing facility at its Seattle, WA site.
